ALLIANCE-TO-END-PLASTIC
7.5.2020 13:02:08 CEST | Business Wire | Press release
The Alliance to End Plastic Waste (the Alliance) today announced a partnership with the ASASE Foundation to support women entrepreneurs working to reduce plastic litter in the community. The initiative called Closing the Loop uses a circular economy model to enable local communities to benefit from discarded plastic waste by collecting, reprocessing and reselling it.
Closing the Loop kicks off the Alliance’s support for projects based in Africa. It was first launched by ASASE in 2018 to provide seed money to equip a plastic waste reprocessing plant and offer technical and business management training to women entrepreneurs to run the recycling plant for profit. In the first twelve months, the project created eight jobs within the community and diverted 35 (metric) tons of plastic from waste. By partnering with the Alliance, the capacity of the reprocessing plant will increase to divert 2,000 (metric) tons of plastic waste per year and create even more jobs.
“A key pillar of ending plastic waste in the environment is the sustainable impact it will bring to the well-being of local communities. Our partnership with ASASE is especially meaningful because Closing the Loop is the right step towards a circular economy model. It directly benefits those living in areas which don’t have access to plastic waste collection and sorting systems. This initiative is a simple but scalable action, supporting the inspiring women of Ghana who are building communities towards a path to end plastic waste in the environment,” said Jacob Duer, President and CEO, Alliance to End Plastic Waste.
“What we value most in our partnership with the Alliance to End Plastic Waste is the access to the expertise in waste management, which we can leverage now in our project, effectively multiplying the impact of the funding provided by the Alliance to our project,” comments Dana Mosora, ASASE Foundation Founder and Managing Director.
The partnership has also opened the possibility to bring in expertise from academic partner, the Swiss Federal Institute of Technology, in areas of developing new end market applications and concepting a new financing system for the management of plastic waste in Ghana.
The recycling plant processes a range of plastic waste from water sachets (LDPE) to shampoo and detergent bottles (HDPE) and large cooking oil containers (HDPE), converting it into regrinds. The regrinds are then sold to recyclers to make items such as pavement blocks, sheets for construction and basins and liners, most of which goes back into the community.
About:
The Alliance to End Plastic Waste is a not-for-profit organization bringing together industry, government, communities, and civil society in the fight to end plastic waste.
ASASE Foundation enables Ghanaian women entrepreneurs to play a key role in cashing-in on the plastic waste trash of Accra for the benefit of their own communities.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200507005346/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Plasma One Launches to Herald a New Era of Stablecoin Banking19.6.2026 14:29:00 CEST | Press release
Plasma has today announced the launch of Plasma One, its flagship financial product designed to make digital dollars usable for everyday spending, sending and earning. Plasma One is designed to make stablecoins feel like money, only better - more accessible, reliable and efficient. For years, stablecoin adoption has been held back by a fragmented system and poor user experience. We have seen wallets in one place, exchanges in another, and costly off-ramps standing between digital dollars and daily life. Plasma One brings that experience together in a single app, giving users a simple way to spend, send and earn with stablecoins from one account with zero fees. Headquartered in London, the city that gave rise to Revolut, Wise and Monzo, Plasma is making a bigger bet, that the next generation of consumer banking will be built on stablecoin rails, not legacy banking infrastructure. Underneath Plasma One is the Plasma Network, Plasma’s own blockchain, purpose-built to move stablecoins inst
IQM Appoints Craig Ciesla, Former Illumina VP, as CTO; Inés de Vega Becomes Chief Scientist19.6.2026 09:00:00 CEST | Press release
Ciesla is a seasoned deep tech executive with more than 25 years of experience delivering products across industries — from startups to Fortune 500 companies. De Vega brings more than 20 years of experience advancing quantum technologies from fundamental research to intellectual property and industrial applications. IQM Quantum Computers, the global leader in superconducting quantum computers, today announced the appointments of Dr. Craig Ciesla as Chief Technology Officer (CTO) and Dr. Inés de Vega as Chief Scientist, as she transitions from her role as Vice President of Quantum Solutions, deepening IQM´s leadership as the company prepares for its planned Nasdaq listing through a merger with Real Asset Acquisition Corp. (Nasdaq: RAAQ). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260619693929/en/ From left to right: Dr. Inés de Vega, Chief Scientist, and Dr. Craig Ciesla, Chief Technology Officer. Ciesla, an experienced d
Teijin Receives Approval for Additional Indications of XEOMIN® for Cervical Dystonia and Blepharospasm in Japan19.6.2026 09:00:00 CEST | Press release
Teijin Pharma Limited, the core company of the Teijin Group’s healthcare business, and Merz Therapeutics GmbH, a leading player in neurology-focused specialty pharma, jointly announced today that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved the additional indications for XEOMIN® (incobotulinumtoxinA) for the treatment of cervical dystonia and blepharospasm. This approval represents the fourth and fifth indications for XEOMIN® authorized in Japan, alongside its existing approvals for the treatment of upper limb spasticity, lower limb spasticity and chronic sialorrhea. Cervical dystonia is a focal dystonia characterized by involuntary contractions of the neck muscles, resulting in abnormal or repetitive movements and postures.1 Blepharospasm is also a focal dystonia, characterized by excessive involuntary contractions of the muscles surrounding the eye.2 Both conditions significantly impact patients’ quality of life. The approval by MHLW is based on Phase III clinic
Incyte Japan Announces Approval of Minjuvi® (tafasitamab) in Combination with Lenalidomide for the Treatment of Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)19.6.2026 08:00:00 CEST | Press release
Incyte Biosciences Japan G.K. today announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved Minjuvi® (tafasitamab) in combination with lenalidomide for the treatment of adults with relapsed or refractory diffuse large B-cell lymphoma (DLBCL). “This approval provides a new option for patients in Japan living with relapsed or refractory DLBCL, an aggressive disease with historically limited treatment options,” said Yasuyuki Ishida, General Manager, Incyte Biosciences Japan. “We are committed to helping address critical unmet needs for patients and their families affected by this challenging cancer.” DLBCL is the most common subtype of non-Hodgkin lymphoma and is an aggressive malignancy of B lymphocytes. While many patients respond to initial therapy, outcomes remain poor for those with relapsed or refractory disease, particularly for patients who are not eligible for autologous stem cell transplant.1 The approval is based on results from the MOR208C203 Trial: L
Amazfit Introduces Helio Strap Pro, Bringing Body-Worn Movement Intelligence to HYROX and Hybrid Training18.6.2026 19:07:00 CEST | Press release
New multi-sensor system captures heart rate, movement quality, stability and muscle load to provide a more complete view of performance under fatigue Amazfit, a leading global smart wearable brand owned by Zepp Health (NYSE: ZEPP), today announced Helio Strap Pro, a body-worn training system designed to help HYROX and hybrid athletes better understand how their bodies perform under load. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260618031434/en/ Amazfit Introduces Helio Strap Pro, Bringing Body-Worn Movement Intelligence to HYROX and Hybrid Training Building on the screen-free Helio Strap, Helio Strap Pro adds a dedicated waist-mounted motion sensor that captures core-body movement and stability during training. Combined with upper-arm heart-rate sensing and compatible Amazfit smartwatches, the system provides a more complete picture of cardio effort, movement quality and muscle load than wrist-based tracking alone. Hel
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom